137 related articles for article (PubMed ID: 5059641)
21. [Treatment with immunosuppressive agents in disseminated lupus erythematosus and in some evolutive nephropathies].
Purice S; Ghelerter L; Matei I; Brunazian G
Stud Cercet Med Interna; 1969; 10(2):147-53. PubMed ID: 5344004
[No Abstract] [Full Text] [Related]
22. Longterm survival of lupus nephritis patients treated with azathioprine and prednisone.
Barnett EV; Dornfeld L; Lee DB; Liebling MR
J Rheumatol; 1978; 5(3):275-87. PubMed ID: 372523
[TBL] [Abstract][Full Text] [Related]
23. [Effect of prednisolone and azathioprine on T- and B-lymphocyte number in peripheral blood of patients with glomerulonephritis and systemic lupus erythematosus].
Shilov EM; Tareeva IE; Gordovskaia NB
Ter Arkh; 1978; 50(6):60-7. PubMed ID: 307828
[No Abstract] [Full Text] [Related]
24. [Effect of prednisolone and heparin on circulating T- and B-lymphocytes in glomerulonephritis and systemic lupus erythematosus].
Tareeva IE; Shilov EM
Klin Med (Mosk); 1978 Jul; 56(7):79-84. PubMed ID: 355719
[No Abstract] [Full Text] [Related]
25. Maximum tolerable dose of cyclophosphamide and azathioprine in Pakistani patients with primary renal disease.
Ali SS; Rabbani MA; Moinuddin SS; Virani S; Farooque F; Salam A; Ahmad A
J Pak Med Assoc; 2004 Jan; 54(1):39-42. PubMed ID: 15058645
[TBL] [Abstract][Full Text] [Related]
26. Novel multiple heterozygous NUDT15 variants cause an azathioprine-induced severe leukopenia in a patient with systemic lupus erythematosus.
Otsuka M; Koga T; Sumiyoshi R; Furukawa K; Okamoto M; Endo Y; Tsuji S; Takatani A; Shimizu T; Igawa T; Kawashiri SY; Iwamoto N; Ichinose K; Tamai M; Nakamura H; Origuchi T; Kawakami A
Clin Immunol; 2019 Mar; 200():64-65. PubMed ID: 30742971
[No Abstract] [Full Text] [Related]
27. Effect of azathioprine on renal histology and function in lupus nephritis.
Shelp WD; Bloodworth JM; Rieselbach RE
Arch Intern Med; 1971 Oct; 128(4):566-73. PubMed ID: 5111661
[No Abstract] [Full Text] [Related]
28. Azathioprine in the treatment of systemic lupus erythematosus. A controlled study.
Sztejnbok M; Stewart A; Diamond H; Kaplan D
Arthritis Rheum; 1971; 14(5):639-45. PubMed ID: 4106177
[No Abstract] [Full Text] [Related]
29. Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus.
Ginzler E; Diamond H; Kaplan D; Weiner M; Schlesinger M; Seleznick M
Arthritis Rheum; 1978; 21(1):37-44. PubMed ID: 414759
[TBL] [Abstract][Full Text] [Related]
30. Psychopathology in systemic lupus erythematosus. II. Relation to clinical observations, corticosteroid administration, and cerebrospinal fluid C4.
Baker M; Hadler NM; Whitaker JN; Dunner DL; Gerwin RD; Decker JL
Semin Arthritis Rheum; 1973; 3(2):111-26. PubMed ID: 4584527
[No Abstract] [Full Text] [Related]
31. A vascular necrosis of the femoral head in childhood systemic lupus erythematosus.
Hurley RM; Steinberg RH; Patriquin H; Drummond KN
Can Med Assoc J; 1974 Oct; 111(8):781-4. PubMed ID: 4424118
[TBL] [Abstract][Full Text] [Related]
32. Systemic lupus erythematosus and lymphoma. A family study.
Berliner S; Shoenfeld Y; Sidi Y; Santo M; Weinberger A; Luria D; Hazaz B; Pecht M; Zaizov R; Pinkhas J
Scand J Rheumatol; 1983; 12(3):310-4. PubMed ID: 6604941
[TBL] [Abstract][Full Text] [Related]
33. Treatment of lupus nephritis with cyclophosphamide.
Cameron JS; Boulton-Jones M; Robinson R; Ogg C
Lancet; 1970 Oct; 2(7678):846-9. PubMed ID: 4097756
[No Abstract] [Full Text] [Related]
34. Cyclophosphamide or azathioprine in lupus glomerulonephritis. A controlled trial: results at 28 months.
Decker JL; Klippel JH; Plotz PH; Steinberg AD
Ann Intern Med; 1975 Nov; 83(5):606-15. PubMed ID: 1106278
[TBL] [Abstract][Full Text] [Related]
35. [Course of nephropathy in systemic lupus erythematosus . Influence of the treatment on clinical symptoms, renal function and histology].
Zech P; Richard P; Blanc-Brunat N; Labeeuw M; Colon S; Pozet N; Dupont E; Fries D; Traeger J
J Urol Nephrol (Paris); 1972 Dec; 78(12):987-93. PubMed ID: 4540960
[No Abstract] [Full Text] [Related]
36. Cytotoxic drug treatment of lupus nephritis.
Donadio JV; Holley KE; Ilstrup DM
Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):178-81. PubMed ID: 7102666
[TBL] [Abstract][Full Text] [Related]
37. Glomerulonephritis in procainamide induced lupus erythematosus: report of a case and review of the literature.
Foucar E; Erickson DG; Tung KS
J Clin Lab Immunol; 1979 Apr; 2(1):79-84. PubMed ID: 95811
[TBL] [Abstract][Full Text] [Related]
38. Multiple dermatofibromas in patients with systemic lupus erythematosus on immunosuppressive therapy.
Newman DM; Walter JB
N Engl J Med; 1973 Oct; 289(16):842-3. PubMed ID: 4763427
[No Abstract] [Full Text] [Related]
39. Evidence for the superiority of immunosuppressive drugs and prednisone over prednisone alone in lupus nephritis. Results of a pooled analysis.
Felson DT; Anderson J
N Engl J Med; 1984 Dec; 311(24):1528-33. PubMed ID: 6390198
[TBL] [Abstract][Full Text] [Related]
40. Marrow granulocyte reserves in the rheumatic diseases.
Kimball HR; Wolff SM; Talal N; Plotz PH; Decker JL
Arthritis Rheum; 1973; 16(3):345-52. PubMed ID: 4708013
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
